Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 7/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5224667 | 1.00 | PIK3C3 (0.37) | PIK3C3TP53PTGS2CTSDBACE1 | |
| SCHEMBL5219084 | 0.97 | CTSD (0.36) | PIK3C3TP53PTGS2CTSDBACE1 | |
| SCHEMBL5224671 | 0.89 | PTGS2 (0.34) | PTGS2SMN1; SMN2KDM4ENPC1RAB9A | |
| SCHEMBL5224678 | 0.89 | PTGS2 (0.34) | PTGS2SMN1; SMN2KDM4ENPC1RAB9A | |
| SCHEMBL5219078 | 0.85 | PTGS2 (0.33) | PTGS2SMN1; SMN2KDM4ENPC1RAB9A | |
| SCHEMBL5219089 | 0.85 | PTGS2 (0.33) | PTGS2SMN1; SMN2KDM4ENPC1RAB9A | |
| SCHEMBL5219097 | 0.85 | PTGS2 (0.33) | PTGS2SMN1; SMN2KDM4ENPC1RAB9A | |
| SCHEMBL5223775 | 0.82 | KDM4E (0.39) | PIK3C3TP53CTSDBACE1BACE2 | |
| SCHEMBL5226784 | 0.82 | PIK3C3 (0.39) | PIK3C3TP53CTSDBACE1BACE2 | |
| SCHEMBL5217755 | 0.79 | CTSD (0.37) | PIK3C3CTSDBACE1BACE2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | disclosed |